Efficacy and safety of apatinib in the second-line treatment of advanced gastric cancer
<b>Objective</b> To explore the efficacy and safety of apatinib in the second-line treatment of advanced gastric cancer, providing a reference to guide treatment decisions for patients with advanced gastric cancer who are unable to endure chemotherapy. <b>Methods</b> A tota...
Saved in:
| Main Author: | GUO Mengya, CHEN Yue, PENG Weiwei, SHA Huanhuan, FANG Ying, ZHOU Guoren |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
The Editorial Department of Chinese Journal of Clinical Research
2025-01-01
|
| Series: | Zhongguo linchuang yanjiu |
| Subjects: | |
| Online Access: | http://zglcyj.ijournals.cn/zglcyj/ch/reader/create_pdf.aspx?file_no=20250106&year_id=2025&quarter_id=1&falg=1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety and efficacy of apatinib in combination treatment versus apatinib as second-line treatment for advanced gastric cancer
by: Zhang Han, et al.
Published: (2025-04-01) -
The evaluation of the efficacy and safety about apatinib combined with immune checkpoint inhibitors in advanced gastric cancer: a real-world study
by: Peng-Fei Zhu, et al.
Published: (2025-06-01) -
Transarterial chemoembolization plus apatinib for unresectable hepatocellular carcinoma: a multicenter, randomized, open-label, phase III trial
by: Xue-Feng Kan, et al.
Published: (2025-05-01) -
Cholesterol confers resistance to Apatinib-mediated ferroptosis in gastric cancer
by: Zhiwei Li, et al.
Published: (2025-07-01) -
A prognostic prediction model for advanced gastric cancer based on Ki67
by: NIU Linjun*,LI Xinzhong,LYU Yongjian
Published: (2025-07-01)